Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

The value-for-money assessment and funding arrangements for high-priced drugs in an era of uncertainty: a comparative analysis of national health technology assessment agencies in South Korea, England, Australia, and Canada
Jihyung Hong, Eun-Young Bae, S. Cha, et al.
BMC Health Services Research (2025) Vol. 25, Iss. 1
Open Access
Managed Entry Agreements: Tools of Necessity, Works in Progress
Paul Beninger
Clinical Therapeutics (2025)
Closed Access
Indication-based pricing of the pharmaceuticals in Croatia: case-study
Ana Bobinac, Luka Vončina, I. Velić, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2025)
Closed Access
Impact of Prior Authorization on Patient Access to Cancer Care
Dario Trapani, Lianne Kraemer, Hope S. Rugo, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 11
What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection into the Past and A Way Forward
Sarin KC, Lydia Lin, Diana Beatriz Bayani, et al.
International Journal of Health Policy and Management (2023)
Open Access | Times Cited: 9
Cell and gene therapy regulatory, pricing, and reimbursement framework: With a focus on South Korea and the EU
Sungkyung Lee, Jong Hyuk Lee
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 9
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
Elvio Emanuele Rossini, Carlotta Galeone, Chiara Lucchetti, et al.
PharmacoEconomics - Open (2024) Vol. 8, Iss. 2, pp. 251-261
Open Access | Times Cited: 2
The impact of level of documentation on the accessibility and affordability of new drugs in Norway
Gro Live Fagereng, Anne Marit Morvik, Sara R. Ulimoen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers
Maximillian Otte, Hans‐Peter Dauben, Jeonghoon Ahn, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024) Vol. 24, Iss. 9, pp. 1061-1066
Closed Access | Times Cited: 1
Financial Characteristics of Outcomes-Based Agreements: What Do Canadian Public Payers and Pharmaceutical Manufacturers Prefer?
Allison Wills, Arif Mitha
Value in Health (2023) Vol. 27, Iss. 3, pp. 340-346
Open Access | Times Cited: 3
Price and reimbursement of medicines when new indications are approved: the results of a survey on ISPOR Italy Rome Chapter members
Eugenio Di Brino, Claudio Jommi
Global & Regional Health Technology Assessment (2023) Vol. 10, pp. 40-45
Open Access | Times Cited: 2
Stakeholder Insights into Czech Performance-Based Managed Entry Agreements: Potential for Transformative Change in Pharmaceutical Access?
Petra Hospodková, Pavel Karásek, Aleš Tichopád
Healthcare (2024) Vol. 12, Iss. 1, pp. 119-119
Open Access
Values, challenges, and responses associated with high-priced potential cures: perspectives of diverse stakeholders in South Korea
Jihyung Hong, Eun-Young Bae, Hye-Jae Lee, et al.
Cost Effectiveness and Resource Allocation (2024) Vol. 22, Iss. 1
Open Access
Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel
Claudio Jommi, Francesca Patarnello, Cosetta Bianchi, et al.
Global & Regional Health Technology Assessment (2024) Vol. 11, Iss. 1, pp. 169-174
Open Access
Overview of Health Technology Assessment Processes for Time-Limited Recommendations
Ari L. Mendell, Christopher Vannabouathong, Kim Le, et al.
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 5
Open Access
Implementing a Managed Entry Agreement Framework in Cyprus
Olga Pitsillidou, Panagiotis Petrou, Maarten J. Postma
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Vol. 23, Iss. 8, pp. 857-865
Closed Access
Page 1

Scroll to top